David Shaw’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.46M Hold
5,000
– – ﹤0.01% 3488
2026
Q2
$1.67M Hold
5,000
– – ﹤0.01% 3351
2026
Q1
$1.61M Hold
5,000
– – ﹤0.01% 3086
2025
Q4
$1.47M Buy
+5,000
New +$931K ﹤0.01% 3279

Other funds holding PRAX

David Shaw's PRAX Position: Q3 2026 in Review

David Shaw increased its Praxis Precision Medicines (PRAX) stake by 55% in Q3 2026, buying an estimated $940K and bringing the position to 7,980 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #3122.

David Shaw first reported a position in PRAX in Q2 2021 and has held it in 13 quarters since. The position peaked at $11M in Q4 2025. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • David Shaw held 7,980 shares of Praxis Precision Medicines worth $2.32M as of Q3 2026.
  • David Shaw bought 2,840 Praxis Precision Medicines shares in Q3 2026, an estimated $940K.
  • Praxis Precision Medicines made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #3122 holding.
  • David Shaw first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 13 quarters since.
  • David Shaw's Praxis Precision Medicines position peaked at $11M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.